Citatuzumab bogatox
From Infogalactic: the planetary knowledge core
Monoclonal antibody | |
---|---|
Type | Fab fragment |
Source | Humanized (from mouse) |
Target | TACSTD1 |
Identifiers | |
CAS Number | 945228-49-9 |
ATC code | none |
UNII | 23J303Z5CA |
Chemical data | |
Formula | C3455H5371N921O1060S18 |
Molecular mass | 77.3 kg/mol |
(what is this?) (verify) |
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ Viventia Biotech Inc.: VB6-845
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Monoclonal antibodies
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs